Delivery Order SPE2DB20D2104-SPE2DB24FU28K

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Focalin XR 10mg capsules. The contract has a ceiling value of $7,348.97 and an ultimate completion date of October 10, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,741,612 units of Focalin XR 5mg capsules. The contract has a ceiling value of $1,977.33 and a period of performance through May 30, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Focalin XR 5 mg capsules. The contract has a ceiling value of $4,343.00 and an ultimate completion date of September 26, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical for delivering a comprehensive range of medical...
This is a delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Focalin XR 30 mg capsules. The contract has a ceiling value of $1,670.67 and runs through August 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Focalin XR 30 mg capsules. The contract has a ceiling value of $1,189.74 and is a Firm Fixed Price agreement with a final completion date of September 18, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide the Focalin XR medication to support the healthcare needs of military...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Focalin XR 15 mg capsules. The contract has a ceiling value of $2,318.90 and an ultimate completion date of March 6, 2024. The award is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Focalin XR 35 mg capsules. The contract has a ceiling value of $6,978.65 and a completion date of August 20, 2024. This is not a set-aside contract. AmerisourceBergen, through its Corporate Office division, will provide the Focalin XR medication to support federal healthcare programs and services. The company holds several...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Focalin XR 25 mg capsules. The contract has a ceiling value of $1,386.67 and an ultimate completion date of July 31, 2024. The order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025 for a wide range of medical commodities to support military healthcare programs....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of Focalin XR 15 mg capsules, a specialty pharmaceutical product, to support military treatment programs and facilities. The firm fixed price contract has a ceiling value of $5,540.92 and a period of performance through March 18, 2024. No...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Focalin XR 15 mg capsules. The contract has a completion date of February 21, 2024 and a potential value of $6,326.28. It is a firm fixed price delivery order with no set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU28K
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Focalin XR 15 mg capsules. The contract has a ceiling value of $2,799.38 and runs through May 2024. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical commodities.

Generated 2/27/25, 10:58 AM